Lipid Nanoparticle Inclusion Prevents Capsaicin-Induced TRPV1 Defunctionalization.
Carmelo PugliaDebora SantonocitoAngela BonaccorsoTeresa MusumeciBarbara RuoziRosario PignatelloClaudia CarboneCarmela ParentiSantina ChiechioPublished in: Pharmaceutics (2020)
Drug encapsulation in lipid nanoparticles produced an optimization of CPS release, thus reducing mice pain behavior and avoiding the effects that are caused by TRPV1 defunctionalization related to a prolonged activation of this receptor.